These metabolic processes can interfere with insulin signalling pathways, contributing to the development of insulin resistance, type 2 diabetes (T2D) and other obesity-associated metabolic diseases (20, 32–34). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.